文献速递肥胖与代谢综合征

瘦素及瘦素受体缺陷全国多中心研究及系统综述

A National Multicenter Study of Leptin and Leptin Receptor Deficiency and Systematic Review.
PubMed 文献 · J Clin Endocrinol Metab · 2023-01-01

该全国多中心研究纳入18例瘦素(LEP)或瘦素受体(LEPR)缺陷患者,结合系统综述共分析152例,发现LEP缺陷以移码变异为主、发病年龄更早、BMI标准差评分更高且高胰岛素血症更常见,11例接受美曲普汀长期治疗,1例因中和抗体失去疗效。

要点

  • LEP缺陷患者诊断年龄更早[3(9)岁 vs 7(13)岁,P=0.02]且BMI标准差评分更高[3.1(2) vs 2.8(1)kg/m2,P=0.02]。
  • LEP缺陷以移码变异最常见(48%),LEPR缺陷以错义变异最常见(35%)。
  • 11例LEP缺陷患者接受美曲普汀治疗,4例治疗超过20年,1例因中和抗体失去疗效。

核心结论

  • LEP缺陷患者移码变异更常见,LEPR缺陷患者错义变异更常见;LEP缺陷患者诊断年龄更早、BMI标准差评分更高且高胰岛素血症比例更高。
  • 11例患者从长期美曲普汀治疗中获益,1例因中和抗体失去疗效。

研究设计与样本

  • 全国多中心研究,队列纳入18例患者(LEP缺陷11例,LEPR缺陷7例),其中8例为既往已报道病例。
  • 2022年7月进行系统文献综述,47项LEP/LEPR研究中入选42项,加上本队列病例共分析152例患者。

主要发现

  • 10例新病例中发现2个新致病性变异:LEP(c.16delC)和LEPR(c.40+5G>C)。
  • LEP缺陷患者诊断年龄为3(9)岁 vs LEPR缺陷患者7(13)岁,P=0.02。
  • LEP缺陷患者BMI标准差评分中位数为3.1(2)kg/m2 vs LEPR缺陷患者2.8(1)kg/m2,P=0.02,且与移码变异更相关(P=0.02)。
  • LEP缺陷患者更易出现高胰岛素血症(P=0.02)。
  • 152例患者中,LEP缺陷以移码变异最常见(48%),LEPR缺陷以错义变异最常见(35%)。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

CONTEXT: Homozygous leptin (LEP) and leptin receptor (LEPR) variants lead to childhood-onset obesity. OBJECTIVE: To present new cases with LEP and LEPR deficiency, report the long-term follow-up of previously described patients, and to define, based on all reported cases in literature, genotype-phenotype relationships. METHODS: Our cohort included 18 patients (LEP = 11, LEPR = 7), 8 of whom had been previously reported. A systematic literature review was conducted in July 2022. Forty-two of 47 studies on LEP/LEPR were selected. RESULTS: Of 10 new cases, 2 novel pathogenic variants were identified in LEP (c.16delC) and LEPR (c.40 + 5G > C). Eleven patients with LEP deficiency received metreleptin, 4 of whom had been treated for over 20 years. One patient developed loss of efficacy associated with neutralizing antibody development. Of 152 patients, including 134 cases from the literature review in addition to our cases, frameshift variants were the most common (48%) in LEP and missense variants (35%) in LEPR. Patients with LEP deficiency were diagnosed at a younger age [3 (9) vs 7 (13) years, P = .02] and had a higher median body mass index (BMI) SD score [3.1 (2) vs 2.8 (1) kg/m2, P = 0.02], which was more closely associated with frameshift variants (P = .02). Patients with LEP deficiency were more likely to have hyperinsulinemia (P = .02). CONCLUSION: Frameshift variants were more common in patients with LEP deficiency whereas missense variants were more common in LEPR deficiency. Patients with LEP deficiency were identified at younger ages, had higher BMI SD scores, and had higher rates of hyperinsulinemia than patients with LEPR deficiency. Eleven patients benefitted from long-term metreleptin, with 1 losing efficacy due to neutralizing antibodies.

来源:J Clin Endocrinol Metab,查看原文。版权归原作者所有。

引用

  1. Besci Ö, Fırat SN, Özen S, et al. A National Multicenter Study of Leptin and Leptin Receptor Deficiency and Systematic Review. J Clin Endocrinol Metab. 2023. PMID: 36825860. doi:10.1210/clinem/dgad099

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。